Pharmacist service for patients with rheumatoid arthritis

Integrated pharmaceutical care service model using personalized mobile applications for patients with rheumatoid arthritis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0006508

Enrollment

282

Registered

2021-08-27

Start date

2021-08-17

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Telepharmacy Care) : 1) Test: In addition to the existing pharmacist service, tele-pharmacy service is implemented at 1-month intervals (medication consultation based on medication adherence im

Usual care with existing pharmacist services provided at local pharmacies

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Among outpatients 18 years of age or older who visit the Department of Rheumatology at Daegu Catholic University Hospital, those who have been diagnosed with rheumatoid arthritis and have received one or more of the following DMARDs - Conventional DMARDs: Hydroxychloroquine, methotrexate, sulfasalazine, bucillamine, leflunomide, tacrolimus - Biologic DMARDs (subcutaneous): etanercept, adalimumab, golimumab, tocilizumab, abatacept - JAK inhibitor: tofacitinib, baricitinb, upadacitinib 2) Patients who started taking a new drug (DMARD, steroid, or analgesic) at the time of randomization 3) Persons with mobile devices (smartphones, etc.) 4) Patients who agreed to participate in the study

Exclusion criteria

Exclusion criteria: 1) Patients who have difficulty responding to written or interview questionnaires due to cognitive impairment, etc. 2) Patients with severe systemic or malignant disease 3) Patients who do not agree to install the medication guide tool (an application or app developed in this study) on the mobile device 4) Patients who do not agree to provide medication information using Multimedia Messaging Service (MMS) 5) Patients judged by other researchers as inappropriate to participate in the study

Design outcomes

Primary

Measure	Time frame
Health-related quality of life (HRQoL) as measured by K-EQ-5D	—

Secondary

Measure	Time frame
Medication adherence measured by Compliance-Questionnaire-Rheumatology in Korean (K-CQR);Medication knowledge;Patient satisfaction with pharmacist services measured by patient satisfaction questionnaire in Korean (K-PSQ);ESR, hs-CRP, pain score mesured by Visual Analogue Scale (VAS), number of joint involvement;unexpected emergency center visit or hospitalization	—

Countries

Korea, Republic of

Contacts

Public ContactYun-Kyoung Song

The Catholic University of Daegu

yksong@cu.ac.kr+82-53-3609-3609

Outcome results